FDA Finalizing Notice-To-Industry Policy, Amid Concerns
This article was originally published in The Gray Sheet
Executive Summary
Device makers see benefit in FDA’s plan to issue “notice to industry” letters when it wants to communicate policy changes quickly, but industry reps emphasize that FDA should not overuse the approach.